UB Paderborn / Katalog / Suche / in CDI

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

Journal of clinical oncology, 2010-06, Vol.28 (16), p.2784-2795

2010

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects

Journal of clinical oncology, 2007-09, Vol.25 (25), p.3991-4008

2007

Volltextzugriff (PDF)

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)

Archives of pathology & laboratory medicine (1976), 2010-07, Vol.134 (7), p.e48-e72

2010

Volltextzugriff (PDF)

American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants

Journal of clinical oncology, 2009-01, Vol.27 (1), p.127-145

2009

Volltextzugriff (PDF)

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Journal of clinical oncology, 2007-01, Vol.25 (1), p.118-145

2007

Volltextzugriff (PDF)

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Archives of pathology & laboratory medicine (1976), 2010-06, Vol.134 (6), p.907-922

2010

Volltextzugriff (PDF)

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

Archives of pathology & laboratory medicine (1976), 2007, Vol.131 (1), p.18-43

2007

Volltextzugriff (PDF)

American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients

Journal of clinical oncology, 2006-06, Vol.24 (18), p.2917-2931

2006

Volltextzugriff (PDF)

Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update

Journal of clinical oncology, 2008-01, Vol.26 (1), p.132-149

2008

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3235-3258

2009

Volltextzugriff (PDF)

Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline

Journal of clinical oncology, 2009-03, Vol.27 (9), p.1502-1516

2009

Volltextzugriff (PDF)

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update

Blood, 2008-01, Vol.111 (1), p.25-41

2008

Volltextzugriff (PDF)

American Society of Clinical Oncology Clinical Practice Guidelines: Opportunities and Challenges

Journal of clinical oncology, 2008-08, Vol.26 (24), p.4022-4026

2008

Volltextzugriff (PDF)

Systematic review on hormone receptor testing in breast cancer

Applied immunohistochemistry & molecular morphology, 2012-05, Vol.20 (3), p.214

2012

Volltextzugriff (PDF)

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

Journal of clinical oncology, 2021-01, Vol.39 (2), p.155-169

2021

Volltextzugriff (PDF)

Annual trends in opioid prescribing for patients (Pts) with metastatic non-small cell lung cancer (mNSCLC): Cancerlinq data analysis, 2010 to 2017

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.2076-2076

2020

Volltextzugriff (PDF)

Chemotherapy drug shortages in the United States: genesis and potential solutions

Journal of clinical oncology, 2012-03, Vol.30 (7), p.692-694

2012

Volltextzugriff (PDF)

Practice Considerations for Participation in the Enhancing Oncology Model

JCO oncology practice, 2022-11, Vol.18 (11), p.737-741

2022

Volltextzugriff (PDF)

5‐α‐Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review

BJU international, 2010-11, Vol.106 (10), p.1444-1451

2010

Volltextzugriff (PDF)

Reply to P.H. Frankel et al

Journal of clinical oncology, 2009-10, Vol.27 (30), p.e165-e165

2009

Volltextzugriff (PDF)

Reply to P.C. Walsh

Journal of clinical oncology, 2009-07, Vol.27 (20), p.e23-e23

2009

Volltextzugriff (PDF)

American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

Gynecologic oncology, 2009-10, Vol.115 (1), p.132-134

Temin, Sarah

2009

Volltextzugriff (PDF)

In Reply

Journal of clinical oncology, 2008-01, Vol.26 (1), p.162-162

2008

Volltextzugriff (PDF)

In Reply

Journal of clinical oncology, 2008-06, Vol.26 (18), p.3098-3100

2008

Volltextzugriff (PDF)

American Society of Clinical Oncology National Census of Oncology Practices: preliminary report

Journal of oncology practice, 2013-01, Vol.9 (1), p.9

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer

American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)

American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients

Use of Epoetin and Darbepoetin in Patients With Cancer: 2007 American Society of Clinical Oncology/American Society of Hematology Clinical Practice Guideline Update

American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction

Use of 5-α-Reductase Inhibitors for Prostate Cancer Chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline

Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update

American Society of Clinical Oncology Clinical Practice Guidelines: Opportunities and Challenges

Systematic review on hormone receptor testing in breast cancer

American Society of Clinical Oncology Road to Recovery Report: Learning From the COVID-19 Experience to Improve Clinical Research and Cancer Care

Annual trends in opioid prescribing for patients (Pts) with metastatic non-small cell lung cancer (mNSCLC): Cancerlinq data analysis, 2010 to 2017

Chemotherapy drug shortages in the United States: genesis and potential solutions

Practice Considerations for Participation in the Enhancing Oncology Model

5‐α‐Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review

Reply to P.H. Frankel et al

Reply to P.C. Walsh

American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

In Reply

In Reply

American Society of Clinical Oncology National Census of Oncology Practices: preliminary report

Suchergebnisse filtern